STUGLIK BRIAN M sold 6.6% of their position (8.10K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $58.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/16/2026ACC: 0001437749-26-020708
+18.90K
Net shares
Net buyer
$58.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
27K acquired · 8.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
28.4%
6/11/2026
94.96K→121.96K
Common Stock
Direct
Shares
−8.10K
Price / share
$7.20
Trade value
$58.31K
% of position
6.6%
6/12/2026
121.96K→113.86K
Total
Net shares
+18.90K
Net value
-$58.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +27K | — | — | 28.4% | 94.96K | 121.96K |
| Common Stock Direct | 6/12/2026 | S · Sale | −8.10K | $7.20 | $58.31K | 6.6% | 121.96K | 113.86K |
| Total | +18.90K | -$58.31K | ||||||
Derivative Transactions0
No derivative transactions reported